Simple blood test may predict Post-Surgery confusion in colorectal cancer patients

NCT ID NCT07597330

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at 590 colorectal cancer patients to develop a risk tool that predicts postoperative delirium—a common complication causing confusion and slower recovery. Researchers combined blood test results (including the TyG index) with patient subtypes to create a scoring system. The goal is to help doctors quickly spot high-risk patients and provide targeted care, though this is only a data-collection study and does not test a new treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could give doctors a simple way to identify patients at high risk for confusion after colorectal cancer surgery, allowing for earlier preventive care.
What could go wrong
This is an observational study that only collects data, so it does not test a new treatment. The risk tool may not be accurate enough for routine use and needs further validation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER (MSI-H) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • The first hospital of lanzhou university

    Lanzhou, Gansu, 73000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.